• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GnRH激动剂治疗抑制性腺功能之前及期间,性早熟男孩的前列腺特异性抗原

Prostate specific antigen in boys with precocious puberty before and during gonadal suppression by GnRH agonist treatment.

作者信息

Juul A, Müller J, Skakkebaek N E

机构信息

Department of Growth and Reproduction, National University Hospital, University of Copenhagen, Denmark.

出版信息

Eur J Endocrinol. 1997 Apr;136(4):401-5. doi: 10.1530/eje.0.1360401.

DOI:10.1530/eje.0.1360401
PMID:9150700
Abstract

UNLABELLED

In healthy boys, the pituitary-gonadal axis exhibits diurnal variation in early puberty. Serum testosterone levels are higher during the night and low or immeasurable during the day. These fluctuating levels of circulating androgens in early pubertal boys are difficult to monitor. Prostate specific antigen (PSA) is a marker of the androgen-dependent prostatic epithelial cell activity and it is used in the diagnosis and surveillance of adult patients with prostatic cancer. We have measured PSA concentrations in serum from boys with precocious puberty before and during gonadal suppression with GnRH agonists to evaluate the effect of normal and precocious puberty on PSA levels and to study the correlation between testosterone and PSA in boys.

METHODS

PSA was measured by an ultrasensitive immunofluorometric assay with a detection limit of 0.03 microgram/l. Testosterone was measured by an RIA with a sensitivity of 0.23 nmol/l, and sex hormone binding globulin was measured by a time-resolved immunofluorescence assay (sensitivity 0.23 nmol/l). Five boys with central precocious puberty (CPP) were studied before and after 12 months of GnRH agonist treatment. Sixty healthy boys (12 in each Tanner stage of puberty) and 37 healthy young males served as controls.

RESULTS

PSA levels were immeasurable in all prepubertal boys, whereas PSA levels increased with increasing stage of pubertal maturation. There was a significant correlation between PSA and testosterone and free androgen indices (r = 0.61 and r = 0.65 respectively, both P < 0.001). All 5 boys with CPP had significantly elevated PSA levels which decreased to very low or immeasurable levels after GnRH agonist treatment.

CONCLUSION

PSA may be a useful marker of testosterone activity in boys with normal or precocious puberty.

摘要

未标注

在健康男孩中,垂体 - 性腺轴在青春期早期呈现昼夜变化。血清睾酮水平在夜间较高,而在白天较低或无法测量。青春期早期男孩体内循环雄激素水平的这些波动难以监测。前列腺特异性抗原(PSA)是雄激素依赖性前列腺上皮细胞活性的标志物,用于成年前列腺癌患者的诊断和监测。我们测量了性早熟男孩在使用GnRH激动剂抑制性腺之前和期间血清中的PSA浓度,以评估正常青春期和性早熟对PSA水平的影响,并研究男孩体内睾酮与PSA之间的相关性。

方法

采用超灵敏免疫荧光分析法测量PSA,检测限为0.03微克/升。采用放射免疫分析法测量睾酮,灵敏度为0.23纳摩尔/升,采用时间分辨免疫荧光分析法测量性激素结合球蛋白(灵敏度0.23纳摩尔/升)。对5名中枢性性早熟(CPP)男孩在GnRH激动剂治疗12个月前后进行了研究。60名健康男孩(青春期各坦纳分期各12名)和37名健康青年男性作为对照。

结果

所有青春期前男孩的PSA水平均无法测量,而PSA水平随着青春期成熟阶段的增加而升高。PSA与睾酮及游离雄激素指数之间存在显著相关性(分别为r = 0.61和r = 0.65,均P < 0.001)。所有5名CPP男孩的PSA水平均显著升高,在GnRH激动剂治疗后降至极低或无法测量的水平。

结论

PSA可能是正常或性早熟男孩睾酮活性的有用标志物。

相似文献

1
Prostate specific antigen in boys with precocious puberty before and during gonadal suppression by GnRH agonist treatment.GnRH激动剂治疗抑制性腺功能之前及期间,性早熟男孩的前列腺特异性抗原
Eur J Endocrinol. 1997 Apr;136(4):401-5. doi: 10.1530/eje.0.1360401.
2
Serum prostate specific antigen, sex hormone binding globulin and free androgen index as markers of pubertal development in boys.血清前列腺特异性抗原、性激素结合球蛋白和游离雄激素指数作为男孩青春期发育的标志物。
Clin Endocrinol (Oxf). 1999 Feb;50(2):203-10. doi: 10.1046/j.1365-2265.1999.00636.x.
3
Serum levels of growth hormone binding protein in children with normal and precocious puberty: relation to age, gender, body composition and gonadal steroids.正常青春期和性早熟儿童的血清生长激素结合蛋白水平:与年龄、性别、身体组成和性腺类固醇的关系。
Clin Endocrinol (Oxf). 2000 Feb;52(2):165-72. doi: 10.1046/j.1365-2265.2000.00923.x.
4
Serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 levels are increased in central precocious puberty: effects of two different treatment regimens with gonadotropin-releasing hormone agonists, without or in combination with an antiandrogen (cyproterone acetate).中枢性性早熟患者血清胰岛素样生长因子I(IGF-I)和胰岛素样生长因子结合蛋白3水平升高:促性腺激素释放激素激动剂两种不同治疗方案的效果,单独使用或联合使用抗雄激素(醋酸环丙孕酮)。
J Clin Endocrinol Metab. 1995 Oct;80(10):3059-67. doi: 10.1210/jcem.80.10.7559897.
5
Serum sex hormone-binding globulin levels in healthy children and girls with precocious puberty before and during gonadotropin-releasing hormone agonist treatment.健康儿童及性早熟女童在促性腺激素释放激素激动剂治疗前及治疗期间的血清性激素结合球蛋白水平。
J Clin Endocrinol Metab. 2007 Aug;92(8):3189-96. doi: 10.1210/jc.2007-0231. Epub 2007 May 22.
6
Serum concentrations of free and total insulin-like growth factor-I, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty.正常或性早熟男孩血清中游离及总胰岛素样生长因子-I、胰岛素样生长因子结合蛋白-1和-3以及胰岛素样生长因子结合蛋白-3蛋白酶活性
Clin Endocrinol (Oxf). 1996 May;44(5):515-23. doi: 10.1046/j.1365-2265.1996.711531.x.
7
Serum inhibin A and inhibin B in central precocious puberty before and during treatment with GnRH agonists.GnRH激动剂治疗前后中枢性性早熟患儿血清抑制素A和抑制素B水平
Horm Res. 2000;54(2):84-91. doi: 10.1159/000053237.
8
Hypothalamo-pituitary-gonadal function in male central precocious puberty.男性中枢性性早熟中的下丘脑-垂体-性腺功能
Clin Endocrinol (Oxf). 1978 Jun;8(6):437-44. doi: 10.1111/j.1365-2265.1978.tb02180.x.
9
Effect of low-dose testosterone treatment on androgen regulated proteins prostate specific antigen and sex hormone binding globulin in short prepubertal boys: lack of initiation of puberty.低剂量睾酮治疗对青春期前矮小男童雄激素调节蛋白前列腺特异性抗原和性激素结合球蛋白的影响:未启动青春期。
J Pediatr Endocrinol Metab. 2003 Jan;16(1):55-62. doi: 10.1515/jpem.2003.16.1.55.
10
Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.正常青春期及真性性早熟患者在使用强效促黄体生成素释放激素激动剂治疗前后的生长调节素C
J Clin Endocrinol Metab. 1985 Jul;61(1):152-9. doi: 10.1210/jcem-61-1-152.